日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer

IGF1R抑制和PD-1阻断可改善上皮性卵巢癌的抗肿瘤免疫反应

Lina Somri-Gannam # ,Shilhav Meisel-Sharon # ,Shay Hantisteanu ,Tomer Bar-Noy ,Emiliya Sigal ,Gabriel Groisman ,Mordechai Hallak ,Haim Werner ,Ilan Bruchim

IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer

IGF1R 轴抑制可恢复卵巢癌中的树突状细胞抗肿瘤反应

Lina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, Gabriel Groisman, Ofer Limonad, Mordechai Hallak, Ilan Bruchim

Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer

鉴定 ZYG11A 为子宫内膜癌中 IGF1 依赖性原癌基因候选者

Laris Achlaug, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Ilan Bruchim, Manisha Dixit, Zvi Laron, Shoshana Yakar, Haim Werner

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

全基因组分析确定细丝蛋白 A 是胰岛素和 IGF1 作用的新型下游靶点

Daniel Aizen, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Ilan Bruchim, Haim Werner

Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners

二甲双胍下调胰岛素/IGF-I信号通路并以p53依赖或非依赖的方式抑制不同子宫浆液性癌(USC)细胞的增殖和迁移

Rive Sarfstein, Yael Friedman, Zohar Attias-Geva, Ami Fishman, Ilan Bruchim, Haim Werner

The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway

组蛋白去乙酰化酶抑制剂伏立诺他的作用机制涉及与胰岛素样生长因子信号通路的相互作用

Rive Sarfstein, Ilan Bruchim, Ami Fishman, Haim Werner